AI assistant
908 Devices Inc. — Director's Dealing 2021
Sep 27, 2021
33342_dirs_2021-09-27_ac7f9f6b-3273-45f7-8b9c-6bf1a199a6f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: 908 Devices Inc. (MASS)
CIK: 0001555279
Period of Report: 2021-09-23
Reporting Person: Basarsky Trent A. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-23 | Common Stock | M | 6000.00 | $1.75 | Acquired | 41000.00 | Direct |
| 2021-09-23 | Common Stock | S | 2128.00 | $37.09 | Disposed | 38872.00 | Direct |
| 2021-09-23 | Common Stock | S | 3872.00 | $38.04 | Disposed | 35000.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-23 | Stock Option (Right to Buy) | $1.75 | M | 6000.00 | Disposed | 2027-04-26 | Common Stock (84504.00) | Direct |
Footnotes
F1: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.59 to $37.56, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $38.38, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4: The shares underlying the option are fully vested and immediately exercisable.